Totus Medicines
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1480 64th St, Emeryville, California, 94...Website
www.totusmedicines.comRevenue
$10.3 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Totus Medicines
Founded in 2019, Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome. Totus is based in Cambridge, Massachusetts.Explore more
Totus Medicines Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Totus Medicines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Totus Medicines has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Totus Medicines has new funding data
Check out if Totus Medicines is spiking on competitors!
Click to see if Totus Medicines had a recent Job posting/layoffs
Totus Medicines, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Totus Medicines recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Totus Medicines launches new products
Congratulate Masked Content for being promoted to Masked Content at Totus Medicines
Recommended Actions
Find VP level buyers at Totus Medicines
Find 3 more new buyers
Compare Similar Companies to Totus Medicines
Compare insights from companies similar to Totus Medicines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Totus Medicines is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Totus Medicines is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Totus Medicines.
Totus Medicines financials insights
Gather financial insights about Totus Medicines, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$40M
2023
Series B
$66M
Totus Medicines Tech Stack
A closer look at the technologies used by Totus Medicines
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Hiring Plans
Totus Medicines has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Totus Medicines News & Media
Totus Medicines to Present Interim Phase 1b Clinical Data for TOS-358 + Fulvestrant Doublet Therapy in HR+/HER- Breast Cancer Patients at ESMO Breast Cancer Annual Congress 2026
TOS-358 is a covalent, pan-mutant, α-specific PI3K inhibitor designed to address key limitations of existing PI3Kα therapies which include limited mutation coverage and poor tolerabilityTotus Medicines to Present First-in-Class Covalent IRF5 Inhibitor Data at AAI IMMUNOLOGY2026
First-in-class, covalent, oral small molecule inhibitor targeting IRF5Totus Medicines Presents Phase 1a Clinical Data for TOS-358, a Covalent PI3Ka Inhibitor, at ESMO TAT 2026
Oral presentation of Ph 1a clinical data highlights potential best-in-class drug profile in heavily pretreated patients with PI3Ka-mutant metastatic breast cancer and other solid tumorsTotus Medicines to Present Updated Phase 1 Clinical Data for TOS-358 at ESMO Targeted Anticancer Therapies Congress 2026
Oral presentation to highlight updated Phase 1 monotherapy safety and efficacy data for TOS-358, a covalent PI3Ka inhibitor
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Totus Medicines
Sign Up For FreeTo access detailed company insights
Founded in 2019, Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome. Totus is based in Cambridge, Massachusetts.... Read More
